In addition, we also evaluated the association between COL6A3 SNPs and lung cancer patients with or without lymph node metastasis (Additional file 5: Table S2) as well as the clinical staging of lung cancer patients (Additional file 6: Table S3). Here, COL6A3 is linked to metastatic malignant neoplasm in the lymph nodes.